Biotebal

Quick links to important sections

Biotebal

Method of action: Nutritive Agent

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Biotebal

Quick Facts

Property Description
Active ingredient Biotin (Vitamin B7)
Form Oral tablet
Pharmacological class Vitamin preparation (Water-soluble B-vitamin)
General purpose Correction of Biotin deficiency
Origin Synthetic pharmaceutical compound

Biotebal: Classification as a Vitamin Preparation

Biotebal is a dedicated medicinal product whose active component is Biotin (INN: Biotinum), officially classified as a water-soluble B-vitamin. It is a single-ingredient preparation formulated as an oral tablet intended for systemic absorption. The brand is typically recognized in European markets for its specific positioning as a high-concentration Biotin source, utilized by adults when nutritional intake alone is insufficient.


The product provides pharmaceutical-grade Biotin, derived as a high-purity synthetic compound, ensuring a consistent therapeutic concentration focused solely on Biotin status. Its classification requires that the substance act as an essential nutritional factor, confirming its core role as a dietary component necessary for biological health. This ensures a targeted approach compared to complex multi-vitamin formulas.

Biotin: The Essential Coenzyme and Metabolic Support

Biotin functions as a crucial coenzyme required for the activity of specific carboxylase enzymes in the body, which are necessary for energy production and the synthesis of macromolecules. This function is clinically recognized for its importance in sustaining general cellular integrity.


This coenzyme activity is fundamental to the metabolic pathways responsible for synthesizing fatty acids, breaking down carbohydrates (glucose), and utilizing specific amino acids (proteins). Since Biotin supports these core metabolic processes, it plays an essential, supportive role in cellular function, growth, and differentiation, particularly in tissues that regenerate quickly, such as the skin and its appendages. The general purpose of Biotebal is thus to address or prevent deficiencies of Vitamin B7, promoting metabolic balance necessary for the sustained health of these tissues.

Regulatory References

  1. MedlinePlus, Biotin entry

What side effects are possible with Biotebal?

Official Regulatory Safety Profile

The official safety information for high-dose Biotin, the active ingredient in Biotebal, is organized around a low incidence of direct patient effects and a critical, formally documented risk related to clinical diagnostics. Direct adverse reactions are typically limited to isolated instances of allergic response.


Direct Adverse Reactions

The incidence of direct adverse effects is generally classified as rare or not known in regulatory documentation. The most frequently cited reactions are manifestations of hypersensitivity or allergic reactions, which may involve the immune system and the skin.

Classification Examples of Reactions
Rare/Not Known Urticaria, facial swelling, skin rash, or in rare cases, anaphylactic reaction.

Safety Constraint: Diagnostic Test Interference

Regulatory agencies, including the FDA and EMA, have formally documented that high doses of Biotin pose a significant safety constraint by interfering with certain clinical laboratory tests (immunoassays) that use biotin-streptavidin technology. This interference can result in falsely high or falsely low test results. A critical concern cited in labeling is the potential for interference with cardiac markers, such as Troponin, which could lead to a serious diagnostic error or misdiagnosis.


Population and Exposure Considerations

The risk of this diagnostic interference is dose-dependent and is specifically associated with consuming high levels of Biotin (typically ge 5 mg/day). Furthermore, the official prescribing information notes that certain groups, such as patients with impaired renal function, may be at a higher risk due to delayed excretion of Biotin, which prolongs the time that plasma levels remain elevated.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information emphasizes that the primary risk associated with high Biotin intake is not clinical toxicity but the potential for severe diagnostic error.

Feature Official Regulatory Statement
Documented Overdose Presentations No known adverse health effects or clinical toxicity are officially documented to result from the intake of extremely high doses. Excess amounts are water-soluble and excreted [^NIH].
Physiological Systems Affected The main documented risk is the interference with in vitro diagnostic tests (e.g., tests for cardiac Troponin, thyroid hormones) that use biotin technology [^FDASafety].
Severity Classification The potential outcome from diagnostic interference is classified as life-threatening, with regulatory reports citing fatal outcomes associated with a missed diagnosis [^FDASafety].

Required Emergency Actions

Action Trigger Label-Derived Phrasing
When Immediate Medical Help Is Required Immediate medical attention is required due to the potential for a missed diagnosis of acute myocardial infarction (heart attack) resulting from falsely low cardiac biomarker results [^FDASafety].
Emergency Response Statement Seek immediate medical attention for suspected overdose or the onset of any severe, acute symptoms. Contact Poison Control centers for guidance in cases of over-exposure [^NIH].

Management and Antidote Status

Management is generally symptomatic and supportive, as no specific antidote is known for Biotin over-exposure [^StatPearls]. The critical procedural action is the cessation of Biotin intake prior to and during specific lab testing to resolve the diagnostic interference [^FDAGuidance].

[^NIH]: NIH Office of Dietary Supplements [^FDASafety]: FDA Safety Communication on Biotin Interference [^FDAGuidance]: FDA Guidance on Testing for Biotin Interference [^StatPearls]: NCBI StatPearls (Biotin entry)

Therapeutic Uses of Biotebal

The medication is commonly used for symptomatic relief in situations where a deficiency in the contained vitamin (biotin) is contributing to symptoms related to systemic imbalance and symptoms related to physical discomfort in structural tissues. A lack of this vitamin may lead to symptoms such as hair loss and brittle nails. It provides support that helps ease the overall symptom burden across key domains where nutrient-driven symptoms create noticeable physiological strain.

The symptomatic areas addressed include excessive hair shedding and thinning, structural issues that manifest as fragile or easily split nails, and specific skin manifestations such as rash or inflammation that may appear around the facial openings in cases of deficiency.

“It is applied in contexts where symptoms are associated with a temporary physiological imbalance, contributing to improved comfort and stability.”

It is used for managing symptom clusters that interfere with daily functioning, providing support that helps maintain a sense of stability during periods of heightened discomfort.


Quick Fact: Relief for Structural Weakness

This medication may assist with managing symptoms related to physical discomfort and instability in the nails and hair, contributing to easing the overall symptom load.

Regulatory References

  1. NIH MedlinePlus overview of Biotin

Eligibility and Restrictions for Use

Eligibility Profile: Who Can and Cannot Use Biotebal

The eligibility for the high-dose Biotin medicinal product, Biotebal, is officially defined by government regulatory documents, focusing on absolute contraindications and population-specific restrictions.

Classification Population Eligibility Status as per Regulatory Label
Contraindication Patients with Hypersensitivity to Biotin or Excipients Absolute Prohibition
Age Group Adults Established Use
Pediatric Use Children and Adolescents Use Not Established

Restrictions and Conditional Use

Official labeling defines specific restrictions based on physiological state and clinical procedures:

  • Pregnancy and Breastfeeding: Use is not recommended in both pregnant and breastfeeding women. This is based on the therapeutic dose significantly exceeding the official recommended daily intake (AI) for these populations.
  • Laboratory Testing: High-dose Biotin can interfere with in vitro diagnostic tests, such as those for cardiac markers (e.g., troponin) and hormones. Patients are required to discontinue the medicine for a specific period before having blood drawn for these assays.
  • Renal Function: Regulatory warnings note that the risk of lab test interference is higher in patients with renal impairment, establishing this as a specific limitation requiring special attention.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section details officially documented interaction patterns for the active ingredient, Biotin, as recorded in government regulatory documents.


Pharmacokinetic and Substance Interactions

Category Documented Interaction Outcome
Anticonvulsants Co-administration with specific agents, including Phenytoin, Carbamazepine, and Phenobarbital, is formally documented to reduce systemic Biotin exposure. This effect results from accelerated enzymatic breakdown (catabolism) of Biotin and inhibition of its intestinal absorption.
Antibiotics Certain antibiotics, such as Macrolides and Fluoroquinolones, may decrease the level of Biotin by altering the intestinal flora, which contributes to endogenous Biotin production. Biotin may also reciprocally decrease the level of Ciprofloxacin.
Food/Substance Ingestion of raw egg white prevents Biotin absorption, as the Avidin protein binds to Biotin in the intestine. Chronic alcohol consumption is also documented to interfere with Biotin absorption.

Administration and Procedural Constraints

  • Mandatory Timing Rule: To mitigate the reciprocal interaction, Ciprofloxacin must be administered at least four hours before or two hours after Biotin.
  • Diagnostic Interference: High concentrations of Biotin are officially documented to cause interference with certain in vitro diagnostic immunoassays that rely on biotin-streptavidin technology. This can lead to falsely high or falsely low test results for markers like troponin or thyroid hormones, a constraint that requires notification of laboratory personnel prior to sample collection.

The regulatory profile does not list any formal contraindications for Biotin with other medicinal products.

Mechanism of Action

The mechanism of action for Biotebal is defined by the essential biological function of its active ingredient, Biotin, as a necessary cofactor that is essential for fundamental metabolic and structural processes.


Coenzyme Activation and Carboxylase Function

The core mechanism involves Biotin covalently binding to and activating five essential biotin-dependent carboxylase enzymes, a process facilitated by holocarboxylase synthetase (HCS). This coenzyme activation is required to allow for the correction of diminished enzyme activity, reactivating the enzymes essential for regulating the synthesis and catabolism of key fatty acids and amino acids.


Metabolic Pathway Requirement for Epithelial Tissues

The reactivated function of the carboxylases directly modulates pathways involved in gluconeogenesis and the utilization of protein precursors. This facilitates the supply of the necessary energy and structural building blocks required by tissues with high cell turnover rates. The cofactor's role in metabolism is required for the continuous, high-demand process of keratin synthesis and proper cellular differentiation in the nail bed and hair matrix, thereby being required for the formation of the keratin infrastructure.

Dosage and Administration Information

How to Use Biotebal

This section outlines the general principles for the administration and dosing of Biotin (Vitamin B7), the active component in Biotebal, as detailed in official guidelines. The medicine is classified as an oral preparation intended for regular, systemic use, typically administered to address Biotin deficiency or related conditions.


Official Administration Guidelines

Feature Detail
Route of administration Oral route (ingestion).
Dosing schedule A daily oral dose typically ranges from 5 mg to 10 mg, as prescribed for deficiency management.
Frequency The medication is generally taken once daily.

Procedural and Contextual Instructions

Administration of the oral tablet must be done using a sufficient amount of water to ensure proper intake. A critical administration constraint outlined in official guidance involves the simultaneous intake of food: patients are instructed to avoid consuming raw egg white near the time of dosing, as it contains avidin which can impair Biotin absorption.

In cases where a dose is missed, instructions advise taking the dose as soon as possible; however, if it is nearly time for the next scheduled dose, the missed dose should be skipped to prevent taking a double dose. The use pattern is defined as regular and continuous over a period determined by the prescribing physician.


Population-Specific Rules

Official labeling for Biotin preparations specifies that use in children and adolescents is not based on a general recommendation. Instead, the specific dose and duration of use for this population must be individually determined by a healthcare professional based on medical advice, aligning with the standards set by health authorities.

Recent Clinical Evidence

Biotebal: Recent Clinical Evidence

Biotebal is a product containing biotin (Vitamin B7, or Vitamin H) as its active substance. Biotin is a water-soluble vitamin essential for various metabolic functions, including the synthesis of keratin, the primary protein structure of hair and nails. Research has focused on its role in addressing symptoms related to biotin deficiency.


A. Clinical Context and Efficacy

Clinical evidence regarding biotin supplementation focuses primarily on individuals with documented biotin deficiency, which is rare in the general population. In cases of true, confirmed biotin deficiency—whether inherited or acquired—supplementation has been observed to address symptoms such as hair loss, brittle nails, and specific skin rashes. However, scientific reviews and analyses generally conclude that robust evidence supporting biotin supplementation for hair growth or quality improvement in otherwise healthy individuals with normal biotin status is limited or absent.

Research has explored whether hair and nail quality showed changes in small cohorts of patients experiencing thinning hair or nail disorders, with outcomes suggesting that subjective improvements were sometimes reported. Larger, randomized, and placebo-controlled trials necessary to confirm a definitive therapeutic benefit for common hair loss conditions are sparse.


B. Safety and Research Considerations

Biotin is generally well-tolerated, even at doses significantly exceeding the recommended daily intake. However, one crucial consideration when using high-dose biotin is its known potential to interfere with certain laboratory tests, including immunoassays used to measure thyroid hormones and cardiac markers. This interference can lead to falsely high or falsely low test results, potentially complicating medical care. For this reason, patients are advised to inform healthcare providers and laboratory staff if they have recently taken high doses of biotin before undergoing blood tests.

Research Focus Primary Observation
Biotin Deficiency Observed symptomatic improvement (hair, nails, skin) when deficiency is confirmed.
Non-Deficient Hair Loss Evidence supporting a significant effect on hair growth or density is limited.
Safety at High Doses Generally well-tolerated, but can interfere with laboratory immunoassay results.

Frequently Asked Questions (FAQ)

Common questions about Biotebal (FAQ)

Q: Is Biotebal classified as a prescription drug or an over-the-counter medicine?

A: Biotebal is legally defined as a medicinal product by regulatory authorities. Depending on the specific dosage and the national regulations where it is sold, this product may be available either over-the-counter (OTC) or only with a medical prescription. Official documentation confirms its classification as a therapeutic agent.

Q: Does Biotebal have uses beyond supporting hair and nail health?

A: According to the official product information, the authorized indication for this medicine is specifically limited to the correction of conditions caused by a Biotin deficiency. While Biotin is essential for many metabolic processes, the regulatory use focuses on addressing symptoms linked to this deficiency, such as issues with hair and nail health.

Q: Is Biotebal the same as a standard B-vitamin complex supplement?

A: Biotebal is classified as a single-ingredient medicinal product, meaning it contains only Biotin as its active component. This is different from complex multi-vitamin formulas, which contain a blend of various B vitamins and other nutritional factors. Official regulatory classifications reflect this targeted, single-substance approach.

Q: How long before a blood test is it generally recommended to stop taking Biotebal to avoid interference?

A: Regulatory guidance is specific on this matter due to the risk of diagnostic interference with certain lab tests. Official regulatory guidance requires that Biotin be discontinued for a specific duration to prevent the medicine from affecting test results. This timeframe is commonly stated as mathbf48 to 72 hours before the blood sample is collected.

Q: Are stomach issues, such as nausea or abdominal pain, listed as possible side effects?

A: Regulatory documentation lists adverse effects for Biotin as generally rare. The most frequently cited reactions are manifestations of hypersensitivity or allergic reactions. Stomach issues, such as nausea or abdominal pain, are not commonly reported in the official safety profile.

Q: What is the guidance regarding the risk of a biotin overdose when taking Biotebal?

A: Biotin is a water-soluble vitamin, meaning the body does not typically store it in excess. According to official regulatory information, cases of intoxication or overdose have not been reported in medical literature, even when very high doses of Biotin have been used.

Q: Does Biotebal have a known interaction with common over-the-counter pain relievers?

A: Regulatory documents detail all known, established drug-drug interactions for Biotin. Official labeling does not list a specific, formal interaction with common over-the-counter pain relievers, such as ibuprofen or acetaminophen.

Q: Can Biotebal be taken alongside hormone medications for thyroid conditions?

A: Official regulatory labeling does not indicate a known drug-drug interaction between Biotin and thyroid hormone replacement medications. However, it is important to remember that high doses of Biotin are known to interfere with the laboratory tests used to measure thyroid hormone levels.

Q: What does the patient leaflet say about Biotebal affecting the ability to drive or use machinery?

A: The official patient leaflet and regulatory labeling contain a dedicated section on operational safety. According to this information, Biotebal is not known to cause drowsiness or other effects that significantly influence the ability to drive or operate machinery.

Q: Is it true that Biotebal contains sorbitol and what does that mean for some users?

A: The official product information documents the full list of inactive ingredients (excipients), including sorbitol. Because of the presence of sorbitol, regulatory warnings advise caution for individuals with known rare hereditary problems of fructose intolerance.

Q: Does Biotebal address the underlying cause of hair loss or is it focused on symptom support?

A: For its authorized purpose, the medicine is intended to correct the underlying Biotin deficiency, which is the established cause of the symptoms it is authorized to treat. Therefore, the therapeutic goal is to address the metabolic cause rather than just managing symptoms.

Q: Does Biotebal have any known effect on body weight or energy metabolism?

A: Official regulatory documentation lists known adverse effects in the safety profile. According to this information, there are no reported known adverse effects of Biotebal on body weight.

Q: Does taking Biotebal change the natural color or texture of hair?

A: Official regulatory documentation lists known adverse effects in the safety profile. Changes to hair color or texture are not included as a listed adverse effect associated with taking the medicine.

Q: Is it generally considered safe to use Biotebal for extended periods of time?

A: The official prescribing information defines the use pattern for the authorized indication as regular and continuous over a period determined by the treating physician. Given that Biotin is known to have low toxicity and overdose is not reported in regulatory literature, this continuous use pattern is consistent with the generally low toxicity reported for Biotin in regulatory literature.

Q: What does the term 'water-soluble vitamin' mean in relation to how Biotebal works?

A: The term 'water-soluble vitamin' means that the substance is dissolved in water upon ingestion and is generally not stored in large amounts in the body. Because Biotin is water-soluble, any excess that the body does not utilize is typically excreted primarily via the urine.

Q: What role does the concentration of biotin (5mg) play compared to amounts found in standard multivitamins?

A: The concentration of Biotin in this medicinal product is defined as a high dose by the product's classification. This high dose is significantly greater than the amounts typically found in standard multi-vitamin supplements and is specifically intended to therapeutically correct or prevent an established deficiency.

Q: Is Biotebal available in generic drug versions containing the same active ingredient?

A: While Biotebal is a branded name, the active ingredient, Biotin, is a common and widely available substance. Due to its common status, other generic medicinal products containing high-dose Biotin are available on the market under different names.

Q: Are there specific medical conditions that are described as making Biotebal unsuitable for use?

A: Official regulatory documents list an absolute contraindication for anyone with hypersensitivity (allergy) to the active substance or its excipients. Additionally, special caution is advised for individuals with impaired renal function because of a heightened risk of diagnostic test interference.

Q: Does Biotebal contain any ingredients besides biotin that are meant to support hair and nails?

A: Biotebal is officially defined as a single-ingredient medicinal product. This means that, apart from its inactive ingredients (excipients), it contains only Biotin as the active component intended to address its authorized purpose.

How should Biotebal be stored and disposed of?

How to Store and Dispose of Biotebal?

The storage and disposal of Biotebal (Biotin oral tablets) must adhere strictly to regulatory conditions to ensure product stability and environmental safety.

Storage Requirements

The medicine must be stored at a temperature not higher than 30 C and must be kept in its original packaging to provide protection from moisture. For safety, Biotebal must remain out of the sight and reach of children. The tablets must not be used after the expiration date (EXP) printed on the packaging.

Disposal Instructions

Regulatory documents state that Biotebal must not be thrown away via wastewater or domestic household waste. To ensure disposal complies with official pharmaceutical waste guidelines, individuals are instructed to ask a pharmacist how to dispose of unused medicines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Biotebal found in:

A-Z Index: